Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
CA 2383347 A1 · Owner: Tachdjian, Catherine · Inventors: Pleynet, David P. M.; Tachdjian, Catherine; Fanjul, Andrea
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes adipocyte differentiation, uncontrolled proliferation such as lymphoma, Hodgkin's Disease, leukemia breast cancer, prostate cancer or cancers in general; and inflammation such , as osteoarthritis, rheumatoid arthritis Crohn's Disease or Inflammatory Bowel Disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 31, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 31, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 31, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.